NO994519L - Fremstilling av pulveragglomerater - Google Patents

Fremstilling av pulveragglomerater

Info

Publication number
NO994519L
NO994519L NO994519A NO994519A NO994519L NO 994519 L NO994519 L NO 994519L NO 994519 A NO994519 A NO 994519A NO 994519 A NO994519 A NO 994519A NO 994519 L NO994519 L NO 994519L
Authority
NO
Norway
Prior art keywords
preparation
powder agglomerates
agglomerates
powder
Prior art date
Application number
NO994519A
Other languages
English (en)
Other versions
NO328062B1 (no
NO994519D0 (no
Inventor
Tsong-Toh Yang
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25232603&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO994519(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO994519D0 publication Critical patent/NO994519D0/no
Publication of NO994519L publication Critical patent/NO994519L/no
Publication of NO328062B1 publication Critical patent/NO328062B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO19994519A 1997-03-20 1999-09-17 Fremgangsmate for fremstilling av agglomerater NO328062B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82112997A 1997-03-20 1997-03-20
PCT/US1998/003799 WO1998041193A1 (en) 1997-03-20 1998-03-16 Preparation of powder agglomerates

Publications (3)

Publication Number Publication Date
NO994519D0 NO994519D0 (no) 1999-09-17
NO994519L true NO994519L (no) 1999-11-19
NO328062B1 NO328062B1 (no) 2009-11-13

Family

ID=25232603

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19994519A NO328062B1 (no) 1997-03-20 1999-09-17 Fremgangsmate for fremstilling av agglomerater

Country Status (26)

Country Link
EP (3) EP0969816B1 (no)
JP (5) JP3901738B2 (no)
KR (1) KR100386055B1 (no)
CN (3) CN100548277C (no)
AR (1) AR011986A1 (no)
AT (2) ATE415149T1 (no)
AU (1) AU741783B2 (no)
CA (3) CA2282360C (no)
CL (1) CL2011000050A1 (no)
CZ (1) CZ295460B6 (no)
DE (2) DE69840277D1 (no)
DK (2) DK1393721T3 (no)
ES (2) ES2316681T3 (no)
HK (2) HK1061359A1 (no)
HU (2) HU230274B1 (no)
ID (1) ID24472A (no)
IL (1) IL131640A0 (no)
MY (1) MY120725A (no)
NO (1) NO328062B1 (no)
NZ (1) NZ337443A (no)
PL (3) PL204480B1 (no)
PT (2) PT969816E (no)
SK (1) SK284919B6 (no)
TW (1) TWI221778B (no)
WO (1) WO1998041193A1 (no)
ZA (1) ZA982254B (no)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9723985D0 (en) * 1997-11-14 1998-01-14 Zeneca Ltd Pharmaceutical compositions
SE9804001D0 (sv) 1998-11-23 1998-11-23 Astra Ab New process
SE9804000D0 (sv) 1998-11-23 1998-11-23 Astra Ab New composition of matter
AR022695A1 (es) * 1999-01-28 2002-09-04 Schering Corp PORTADOR SoLIDO PARTICULADO Y MÉTODO PARA PROVEER CONTROL DE LA PARTICULADA PARA LA DISTRIBUCIoN DE TAMANO DE PARTíCULAS Y DE CONTENIDO AMORFO CONVERTIBLE DURANTE SU PREPARACION
US6623760B1 (en) 1999-01-28 2003-09-23 Schering Corporation Method of preparing particles for agglomeration
GB9903759D0 (en) * 1999-02-18 1999-04-14 Novartis Ag Organic compounds
GB9904919D0 (en) 1999-03-03 1999-04-28 Novartis Ag Organic compounds
CA2382216A1 (en) * 1999-08-20 2001-03-01 Xian Ming Zeng Method to produce powders for pulmonary or nasal administration
GB0009612D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic formulations
GB0009609D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic compositions
GB0009605D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medicaments
FI20002177A0 (fi) * 2000-10-02 2000-10-02 Orion Yhtymae Oyj Uusi yhdistelmä astman hoitoon
FI20002216A0 (fi) * 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit astman hoitoon
FI20002215A0 (fi) * 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
ITMI20012174A1 (it) * 2001-10-18 2003-04-18 Univ Parma Polvere per somministrazione nasale di farmaci
US7931022B2 (en) 2001-10-19 2011-04-26 Respirks, Inc. Method and apparatus for dispensing inhalator medicament
EP1452179A1 (en) * 2003-02-27 2004-09-01 CHIESI FARMACEUTICI S.p.A. Novel medicament combination of a highly potent long-lasting beta2-agonist and a corticosteroid
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
CA2534693A1 (en) * 2003-08-05 2005-02-17 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising steroids and a betamimetic
MXPA06003376A (es) * 2003-09-26 2006-06-08 Schering Corp Tratamiento de enfermedad pulmonar.
CA2543482A1 (en) * 2003-10-28 2005-05-19 Glaxo Group Limited Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
JP2007513145A (ja) * 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 医薬用多微粒子の製造方法
JP2007513139A (ja) * 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 安定性の改善した多粒子組成物
SE528121C2 (sv) * 2004-03-29 2006-09-05 Mederio Ag Preparering av torrpulver för på förhand uppmätt DPI
IL168603A (en) * 2005-05-16 2011-05-31 Resdevco Res And Dev Co Pharmaceutical or cosmetic composition for the prevention and treatment of irritation of mucous cells or skin cells
DE102006030166A1 (de) * 2006-06-29 2008-01-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tempern
DE102006053375A1 (de) * 2006-11-10 2008-05-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Mischung von Pulvern
TW201024034A (en) 2008-12-30 2010-07-01 Saint Gobain Abrasives Inc Bonded abrasive tool and method of forming
WO2010124198A2 (en) * 2009-04-24 2010-10-28 Schering Corporation Agglomerate formulations useful in dry powder inhalers
KR20170070274A (ko) 2009-05-29 2017-06-21 펄 테라퓨틱스 인코포레이티드 지속형 무스카린 안타고니스트 및 지속형 ｂ₂아드레날린 수용체 아고니스트의 폐 전달용 조성물, 및 연관된 방법 및 시스템
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
GB0918150D0 (en) * 2009-10-16 2009-12-02 Jagotec Ag Improved formulations
MX2012012045A (es) * 2010-04-21 2012-12-17 Chiesi Farma Spa Proceso para proporcionar particulas con cargas electrostaticas reducidas.
JP6454323B2 (ja) 2013-03-15 2019-01-16 パール セラピューティクス，インコーポレイテッド 粒子状結晶性材料のコンディショニングのための方法及びシステム
JP6020489B2 (ja) 2014-02-27 2016-11-02 トヨタ自動車株式会社 昇圧コンバータ及びその制御方法
US10806770B2 (en) 2014-10-31 2020-10-20 Monash University Powder formulation
MX2018008348A (es) * 2016-01-08 2018-12-06 Theron Pharmaceuticals Inc Composiciones de inhalador de polvo seco de derivados de 7-azoniabiciclo[2.2.1]heptano.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1520247A (en) 1974-08-10 1978-08-02 Fisons Ltd Pelletised medicament formulations
US4161516A (en) 1975-07-25 1979-07-17 Fisons Limited Composition for treating airway disease
GB8334494D0 (en) 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
DE59100388D1 (de) * 1990-01-29 1993-10-28 Ciba Geigy Verfahren und Vorrichtung zur Dosierung eines feinkörnigen Pulvers.
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
SE9101090D0 (sv) * 1991-04-11 1991-04-11 Astra Ab Process for conditioning of water-soluble substances
CA2356145A1 (en) * 1991-12-18 1993-06-24 Aktiebolaget Astra New combination of formoterol and budesonide
AU683036B2 (en) 1992-12-18 1997-10-30 Merck Sharp & Dohme Corp. Inhaler for powdered medications
IS1736B (is) 1993-10-01 1999-12-30 Astra Ab Aðferð og tæki sem stuðla að aukinni samloðun agna
PL175564B1 (pl) * 1993-10-01 1999-01-29 Astra Ab Sposób i urządzenie do formowania leku w proszku oraz lek w proszku
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
SK76797A3 (en) * 1994-12-22 1998-02-04 Astra Ab Therapeutic preparation for inhalation containing parathyroid hormone, pth

Also Published As

Publication number Publication date
CL2011000050A1 (es) 2011-06-24
CZ323399A3 (cs) 2000-02-16
AU6537898A (en) 1998-10-12
CA2282360A1 (en) 1998-09-24
EP2036544A1 (en) 2009-03-18
EP1393721A1 (en) 2004-03-03
CN1257423A (zh) 2000-06-21
NO328062B1 (no) 2009-11-13
TWI221778B (en) 2004-10-11
KR100386055B1 (ko) 2003-06-09
PL335742A1 (en) 2000-05-08
EP0969816A1 (en) 2000-01-12
MY120725A (en) 2005-11-30
AU741783B2 (en) 2001-12-06
HUP0002029A3 (en) 2001-02-28
EP1393721B1 (en) 2008-11-26
PT969816E (pt) 2005-04-29
JP2006152000A (ja) 2006-06-15
DK1393721T3 (da) 2009-03-30
JP2014037446A (ja) 2014-02-27
EP0969816B1 (en) 2004-12-15
ES2234102T3 (es) 2005-06-16
PL204480B1 (pl) 2010-01-29
JP3901738B2 (ja) 2007-04-04
NO994519D0 (no) 1999-09-17
CZ295460B6 (cs) 2005-08-17
ATE284677T1 (de) 2005-01-15
JP5523240B2 (ja) 2014-06-18
HK1021323A1 (en) 2000-06-09
DE69828155T2 (de) 2005-12-22
CN100548277C (zh) 2009-10-14
DE69828155D1 (de) 2005-01-20
ES2316681T3 (es) 2009-04-16
EP2036544B1 (en) 2016-12-28
IL131640A0 (en) 2001-01-28
CA2481868A1 (en) 1998-09-24
CN1903179A (zh) 2007-01-31
ZA982254B (en) 1998-09-17
NZ337443A (en) 2001-04-27
HK1061359A1 (en) 2004-09-17
JP2000510478A (ja) 2000-08-15
CA2282360C (en) 2004-11-09
JP2010248260A (ja) 2010-11-04
HU230274B1 (hu) 2015-11-30
HUP0002029A2 (hu) 2000-11-28
CA2481868C (en) 2010-06-15
CN1552310A (zh) 2004-12-08
JP2010275316A (ja) 2010-12-09
AR011986A1 (es) 2000-09-13
CN100518718C (zh) 2009-07-29
ID24472A (id) 2000-07-20
CN1149076C (zh) 2004-05-12
PL192441B1 (pl) 2006-10-31
DE69840277D1 (de) 2009-01-08
HU226671B1 (en) 2009-06-29
SK128099A3 (en) 2000-06-12
SK284919B6 (sk) 2006-02-02
CA2706634A1 (en) 1998-09-24
WO1998041193A1 (en) 1998-09-24
PL208480B1 (pl) 2011-05-31
CA2706634C (en) 2012-10-23
HU0600845D0 (en) 2007-01-29
PT1393721E (pt) 2009-02-02
DK0969816T3 (da) 2005-03-14
ATE415149T1 (de) 2008-12-15
KR20010005520A (ko) 2001-01-15

Similar Documents

Publication Publication Date Title
NO994519D0 (no) Fremstilling av pulveragglomerater
EE04420B1 (et) Pulberinhalaator
DE69932552D1 (de) Pulver-Zusammensetzung und kosmetische Zusammensetzung enthaltend dieselbe
DE69708327D1 (de) Pulverinhalator
DE19681727T1 (de) Kapseln/Teilchen enthaltende Shampoo-Zusammensetzung
ID18427A (id) Pengkabut serbuk
DE69725265D1 (de) Pulverlack
NO981166L (no) Fremstilling av askorbylmonofosfater
PL341049A1 (en) Agglomerates of particles
NO981774D0 (no) Fremstilling av L(+) - laktat
DE59909297D1 (de) Carbonyleisensilizid-Pulver
DE59810370D1 (de) Pulverlack
DE69717521D1 (de) Pulverlack
NO20016151D0 (no) Fremstilling av substituerte piperidin-4-oner
ATE217335T1 (de) Farbige pulverförmige beschichtungsmasse
NO20003182L (no) FremgangsmÕte for inhalering av pulverstoffer
ID19844A (id) Komponen tumbukan
PL332833A1 (en) Cut-off acetylhydrolase of thrombocytes activating factor
NO991148D0 (no) Fremstilling av 1-butyl-4-piperidinyl-metylamin
NO982531D0 (no) Fremstilling av <alfa>-tokoferol
GB2329582B (en) Powder Puff
ID23295A (id) Komposisi bedak bubuk talek
DE59807895D1 (de) Pulverklarlack
NO982673D0 (no) Fremstilling av kitosan
SE9703829D0 (sv) Powder inhaleri

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: MERCK SHARP AND DOHME CORP

Free format text: NEW ADDRESS: 126 EAST LINCOLN AVENUE, US-NJ07065 RAHWAY, US

MK1K Patent expired